The cytochrome bc 1 complex (bc 1 ) is a widespread, dimeric redox-driven proton translocase. It oxidizes molecules of ubiquinol (UQH2) in the site Q P of the cytochrome b subunit, whereby the two released electrons are transferred, respectively, to the heme of cytochrome c 1 -via the mobile soluble domain of the Rieske protein (the ''head'' domain) -and to a ubiquinone (UQ) molecule in the Q N site of cytochrome b. Earlier kinetic studies have indicated that the movement of the Rieske ''head'' domain could be coupled with the quinone reduction in the Q N site. Thermodynamics considerations also indicate that the ability of the Rieske ''head'' domain in one monomer to move towards cytochrome c 1 might be coupled with the docking of the ''head'' domain to cytochrome b in the other monomer. However, the details of such mechanistic coupling within the bc 1 dimer remain elusive.
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Understanding Kinase Activation of ALK in Neuroblastoma Patients Peter J. Huwe, Scott Bresler, Jin Park, Mark Lemmon, Ravi Radhakrishnan. University of Pennsylvania, Philadelphia, PA, USA. Activating mutations in the kinase domain of anaplastic lymphoma kinase (ALK) have been implicated in the early childhood cancer, neuroblastoma. using molecular dynamics based methods, we investigate how these point mutations promote constitutive kinase activation in neuroblastoma patients. We analyze the solvent-accessible surface area, hydrogen-bond occupancies, water density fluctuations, and principal components of motion of key regions of the protein and apply scoring functions to these analyses to characterize each mutation's mode of activation. We compare our results to biochemical rate constants and clinical data to confirm the relevancy of our findings. Our results demonstrate that these mutations may disrupt key hydrophobic and hydrophilic networks which stabilize the inactive conformation of the kinase domain and suggest that computational modeling may be a useful tool in predicting which receptor tyrosine kinase mutations are activating. A large number of biological processes, such as protein trafficking, are regulated by motifs that guide proteins to curved membranes. These unstructured motifs in solution fold into an amphipathic alpha-helix at the membrane interface. One of them is the ALPS (Amphipathic Lipid Packing Sensor) motif of the ArfGAP1 protein involved in uncoating of COPI vesicles. Bigay et al. proposed in 2003 that ALPS does not recognize curvature per se but rather packing defects that arise from membrane bending. Here, we performed molecular dynamics simulations to characterize lipid packing defects and understand how ALPS recognizes these defects. First, we show that packing defects can occur by introducing conical lipids such as dioleoylglycerol (DOG) into a flat phosphatidylcholine bilayer. Interestingly, the size and number of defects resemble those observed in a convex membrane by Voth and colleagues. Second, we observe that ALPS binding to the bilayer interface is driven by the insertion of bulky hydrophobic residues into large pre-existing packing defects. Remarkably, these defects do not co-localize with DOG lipids and are evenly distributed. We simulate a large patch of membrane (130x10x20 nm) using the Martini coarse grained force field for lipids. The large size of the membrane enables access to long wavelength fluctuations, which allows us to compute a fluctuation spectrum (fluctuation amplitude at different wavelengths). The spectrum contains both a tension dominated and a bending rigidity dominated regime on wavelengths well above the protrusion regime [1] or molecular tilt regime [2] . The fluctuation spectrum can then be fitted to the prediction of to the standard Helfrich effective Hamiltonian [3], like in flickering experiments. The tension used in the fit of the fluctuation spectrum is calculated directly from the lateral stresses, and our only fit parameter is then the bending rigidity. We establish an overall consistency of the bending rigidity obtained from fits of the fluctuation spectrum for membranes with different tensions. We have also applied an electric field on the membrane. The electric field will change the lateral stress profile of the membrane and the change of the fluctuation spectrum is studied in detail. In particular, the response of the membrane stress profile to the applied electric field is compared to our recent theory [4] .
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The Structural Basis of Cholesterol Activation in Membranes Brett N. Olsen 1 , Agata Bielska 1 , Michael Daily 2 , Paul Schlesinger 1 , Nathan Baker 2 , Daniel Ory 1 . 1 Washington University, St. Louis, MO, USA, 2 Pacific Northwest National Laboratory, Richland, WA, USA. Regulation of cholesterol homeostasis is essential to mammalian cell function, and multiple response pathways are responsible for detecting and maintaining cholesterol levels in different membranes. Recent work has suggested that these pathways selectively respond to an active form of cholesterol that is observed only above a threshold concentration. However, the differences between active and inactive forms of cholesterol are still poorly understood. To identify structural changes in cholesterol-membrane interactions associated with activation, we use molecular dynamics simulations of phospholipid/cholesterol membrane bilayers to obtain atomic-level detail of how the dynamic structure of membranes is perturbed as the cholesterol concentration increases, which are analyzed for changes consistent with activation. We find that at high cholesterol concentrations, cholesterol becomes significantly more exposed to solvent and partially shifts out of the membrane. This effect is seen in membranes composed of either saturated or unsaturated lipids, and shifts in experimentally measured activation thresholds with membrane composition are consistent with changes in increased cholesterol exposure in simulations. We have identified several structural changes in cholesterol within membranes coincident with cholesterol activation as measured in experimental systems. These results demonstrate that the activation of cholesterol believed to be responsible for regulating cholesterol trafficking and homeostasis has a common structural basis in its interactions with the membrane. Future studies will focus on validation of these simulated results with biophysical and spectroscopic experiments and exploration of the effects of small molecules on cholesterol activation. Wednesday, February 6, 2013
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